Dabigatran Etexilate

Dabigatran Etexilate•Cardiometabolic diseases
CAS: 211915-06-9
MF: C34H41N7O5
MW: 627.73
Indications
Therapeutic Target
PT
Usage
Specification
Product Description

Overview

Physicochemical Properties

MSDS Information

Experimental Data

Pharmacodynamics

Mechanism Of Action

Similar Products